Navigation Links
Implementing a therapeutic hypothermia program for post-cardiac arrest in acute care hospitals
Date:8/2/2012

New Rochelle, NY, August 2, 2012National guidelines recommend the use of therapeutic hypothermia to improve outcomes in patients who suffer a heart attack outside of a hospital. The results of a survey of all 73 acute care hospitals in New Jersey evaluating the adoption and implementation of this life-saving treatment from 2004-2011 is published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Therapeutic Hypothermia and Temperature Management website at http://www.liebertpub.com/ther.

Therapeutic hypothermia (TH) involves reducing the body temperature to below normal levels for a prolonged period to minimize the potential damage caused by traumatic or ischemic injury that reduces blood flow to the tissues.

Factors contributing to the initially slow and more recently accelerated implementation of TH in New Jersey hospitals are described by Derek DeLia and colleagues from Rutgers University (New Brunswick, NJ), University of Alabama at Birmingham, Saint Barnabas Medical Center (Livingston, NJ), and Newark Beth Israel Medical Center (Newark, NJ). The authors discuss the wide variation observed in the criteria for patient selection for TH across hospitals and the impact that variations in TH use can have on patient care in the article "Post-Cardiac Arrest Therapeutic Hypothermia in New Jersey Hospitals: Analysis of Adoption and Implementation."

"This communication is important because it focuses on the need of continued adoption and utilization of therapeutic hypothermia targeting cardiac arrest," says W. Dalton Dietrich, PhD, Editor-in-Chief of the Journal and Kinetic Concepts Distinguished Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine. "It is hoped that this journal will continue to provide guidance as more hospitals and treating physicians use this beneficial treatment in limiting the devastating consequences of brain injury."


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related medicine news :

1. New guidelines deliver concise messages for implementing cardiovascular prevention
2. Targeted therapeutics for colon cancer to be presented at AACR meeting
3. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. FORMA Therapeutics teams with TGen Drug Development
6. Device implanted in brain has therapeutic potential for Huntingtons disease
7. Enzyme offers new therapeutic target for cancer drugs
8. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
9. Neurons derived from cord blood cells may represent new therapeutic option
10. Experimental drug may extend therapeutic window for stroke
11. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Implementing a therapeutic hypothermia program for post-cardiac arrest in acute care hospitals
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , ... announced it has partnered with WALLIX to expand its solution to help ... , There are a number of ways to address the authentication requirements within ...
(Date:7/24/2017)... ... July 24, 2017 , ... A CDC study shows that, although people are taking more ... 18 to 29), had at least one case of sunburn within the past year. It’s ... people to ignore the issue. However, only recently have people become conscientious of the risks ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... Harbor, MD. This year's theme focuses on the new ISO/IEC 17025 standards. This ... and integrity in testing and calibration will be changed. , As an ...
(Date:7/24/2017)... ... 24, 2017 , ... Paul Vitenas, MD, FACS is excited to report that ... to attend Allergan’s recent meeting with their Plastics Advisory Board. As one of the ... is bringing a newly defined structure to the aesthetics market. Dr. Vitenas , ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed ... they have enrolled over 100,000 children in their treatment program. Clubfoot is a ... in areas where treatment is limited or non-existent. Without intervention, these children are ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... founder of Echenberg Institute, is announcing a new safe and effective at-home ... and other painful pelvic pain conditions such as pelvic floor dysfunction, vulvodynia, ... ... ... start-up company, VuVatech LLC, fills a void in the women,s wellness market ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
Breaking Medicine Technology: